What Affects IVF Success Rates in Georgia? Key Factors and In-Depth Analysis

Author: Reproductive Medicine Knowledge Editor

📘 Reproductive Medicine Knowledge Base · Edited & Compiled

Direct Answer: The success rate of IVF in Georgia is primarily influenced by the following six dimensions: patient age and ovarian reserve, embryo chromosomal euploidy rate, reproductive center laboratory technical level, degree of individualized ovarian stimulation protocol, uterine environment and implantation window, and male sperm quality. These factors overlap, causing the success rate between different couples at the same clinic to vary by more than 30%.

1. Age and Ovarian Reserve: The Most Core Individual Variable

A. Direct Answer to the Question
Age is the single most important independent factor affecting IVF success rates in Georgia. For women under 38, the live birth rate using their own eggs is typically between 40% and 55%; for those over 40, it drops sharply to 15%–25%; beyond 43, the live birth rate falls below 5%.

B. Why Age Is So Critical
Egg quality declines with age, manifested by an increased rate of meiotic errors, mitochondrial dysfunction, and a higher proportion of chromosomal aneuploidy. Even if enough eggs are retrieved after stimulation, the rate of chromosomally normal embryos decreases significantly. For example, about 60% of blastocysts from a 35-year-old woman are euploid; by age 42, this proportion drops to less than 20%.

D. Differences Across Age Groups

Age Group	Average Number of Eggs Retrieved	Blastocyst Euploidy Rate	Estimated Live Birth Rate per Single Transfer
≤35 years	12–18	55%–65%	45%–55%
36–39 years	8–14	35%–50%	30%–40%
40–42 years	5–10	15%–25%	15%–25%
≥43 years	2–6	<10%	<5%

2. Chromosomal Euploidy Rate: The Actual Contribution of PGT-A

G. The Most Easily Overlooked Detail
Many patients assume that a "high-grade embryo" equals a "good embryo." In reality, morphological grading only reflects developmental speed and fragmentation rate; it cannot determine whether the chromosome number is normal. Some reproductive centers in Georgia routinely recommend PGT-A (Preimplantation Genetic Testing for Aneuploidy), but it is not suitable for all couples. For example, when the mother is under 35 and has an adequate number of embryos, PGT-A can increase the single-transfer success rate to over 60%. However, if ovarian reserve is poor and only 2–3 blastocysts are obtained, biopsy may damage the embryos, potentially reducing the cumulative live birth rate.

H. Common Pitfalls
A few clinics exaggerate the "PGT-A guarantees success" effect. In reality, 15%–20% of euploid embryos still fail to implant due to endometrial receptivity, embryonic metabolic issues, or laboratory handling damage. PGT-A can only screen for chromosomally normal embryos; it cannot solve uterine or immune problems.

L. Interpretation of Test Indicators
Cumulus cells obtained after follicle puncture, polar body biopsy, or trophectoderm biopsy of blastocysts can all be used for PGT. Results are typically reported as "euploid," "aneuploid," or "mosaic." Mosaic embryos (20%–80%) carry a risk of miscarriage after implantation, and a genetic counselor should assess the proportion and type of abnormality to determine transplantability.

3. Laboratory Technical Level: Differences Between Centers in Georgia

R. Observations from Practitioners
Based on data from Georgian reproductive centers over the past three years, laboratory hardware (air filtration systems, laminar flow configuration, time-lapse incubators), embryologist experience (ICSI proficiency, freeze-thaw survival rates), and quality control systems (pH value, temperature stability) directly affect blastocyst formation and thaw survival rates. Top-tier laboratories can maintain a freeze-thaw survival rate of over 98%, while some smaller labs may only achieve 85%–90%. A few percentage points difference in survival rate can mean the difference between 0 and 1 for patients with only 1–2 embryos.

When is it suitable to choose a high-level laboratory?
Patients who are older (≥40 years), have recurrent implantation failure, or have a low number of eggs (<6) should prioritize laboratories with the following features: Thermo Fisher or ESCO brand laminar flow systems, EmbryoScope time-lapse imaging, embryologists with ≥10 years of experience, and ≥500 cycles performed annually.

What should be noted?
Although some centers in Georgia claim "international laboratory standards," it is advisable to request objective data from the past year, such as cold chain monitoring records, ICSI fertilization rates, and blastocyst formation rates (stratified by patient age), rather than relying solely on brochures.

4. Individualization of Ovarian Stimulation Protocols: Dosage and Timing

M. Case Scenario Analysis
A 39-year-old woman with AMH 1.2 ng/mL used a conventional long protocol at Center A with 300 IU Gonal-f, retrieving 5 eggs, but 3 were immature. After switching to Center B, the doctor reviewed her previous follicle development pattern and used a PPOS protocol combined with growth hormone pretreatment. She again retrieved 6 eggs, with a 100% maturity rate, ultimately forming 2 euploid blastocysts, leading to a successful pregnancy after transfer. The same patient, same constitution, but vastly different outcomes due to different stimulation protocols.

B. Why Individualized Protocols Matter
Everyone has different FSH receptor sensitivity, LH levels, and androgen backgrounds. Fixed doses or "one-size-fits-all" protocols can lead to asynchronous follicle development, premature ovulation, or poor egg quality. Doctors in Georgia need to combine AMH, antral follicle count, and previous cycle responses to determine the starting dose and trigger timing.

Suitable for PPOS protocol: Patients with elevated LH in the follicular phase, polycystic ovary morphology, or high risk of previous ovarian hyperstimulation.
Suitable for antagonist protocol: Normal responders, offering high flexibility.
Suitable for mild stimulation/clomiphene: AMH ≤0.5, or those wishing to reduce high-dose medication exposure.

5. Uterine Environment and Implantation Timing

Specific Process and Preparation
Before transfer, the following should be completed: ① Hysteroscopy (to rule out polyps, adhesions, endometritis); ② Endometrial microbiome testing (already available in some centers by 2025); ③ Endometrial thickness and blood flow assessment (≥7mm and blood flow type III); ④ Accurate calculation of the implantation window after progesterone trigger.

How long does it take?
From the start of endometrial preparation on day 2 of menstruation to the transfer day, it takes about 18–25 days. If hysteroscopic surgery is needed, an additional 1–2 cycles are required.

What are the risks?
① Thin endometrium (<6mm) leading to implantation failure; ② Chronic endometritis (CD138 positive) left untreated, making implantation difficult even for euploid embryos; ③ Displaced implantation window (ERA testing shows a standard day 5 blastocyst needs to be transferred on day 6).

6. Male Sperm Quality: Beyond Routine Parameters

L. Interpretation of Test Indicators
Routine semen analysis (concentration, motility, morphology) can only rule out basic issues. More subtle influencing factors include:

Sperm DNA Fragmentation Index (DFI): >30% significantly reduces blastocyst formation and live birth rates. Some centers in Georgia can perform DFI testing, but it is not yet widespread.
Sperm Chromosomal Aneuploidy: Patients with severe oligoasthenospermia (especially Y-chromosome microdeletions) may have sperm chromosomal abnormalities, leading to recurrent miscarriage.
Oxidative Stress: Varicocele, smoking, and high-temperature environments can increase reactive oxygen species, damaging sperm DNA.

When is DFI testing needed?
① Previous IVF cycle with low blastocyst formation rate (<30%); ② Recurrent pregnancy loss (with chromosomally normal miscarriages); ③ Advanced maternal age (≥40) with normal female workup; ④ History of varicocele or genitourinary infection.

7. Special Situation Management: Multi-Cycle Accumulation Strategy

N. Special Situation Management
For women with very low ovarian reserve (AMH <0.3) or advanced age (≥43), the success rate per single cycle is extremely low. Some centers in Georgia allow "egg accumulation" — retrieving eggs over 2–3 consecutive cycles, freezing the obtained eggs or embryos, and then transferring them all at once. This strategy can achieve a cumulative live birth rate 2–3 times that of a single cycle. However, it is important to note that there should be at least one menstrual cycle interval between each retrieval, with a total duration of about 3–5 months.

How to determine if egg accumulation is suitable?
The doctor will assess: ① Whether a dominant follicle still develops each month; ② Whether the patient can tolerate multiple punctures; ③ Financial and time costs. Suitable candidates: AMH 0.3–0.8, age 40–43, with ≤3 eggs retrieved in a previous single cycle.

Common Misconceptions and Frequently Asked Questions

H. Common Pitfalls
Misconception 1: "IVF success rates in Georgia are as high as 80%" — this usually refers to the clinical pregnancy rate rather than the live birth rate, and often only includes data from optimally selected patients under 35. The true live birth rate should consider the overall live birth rate across all age groups, which is typically between 35% and 45% for most institutions.

Misconception 2: "Going directly to Georgia for IVF is cheaper and has a higher success rate than at home" — success depends on individual factors and laboratory standards, not a geographical label. When choosing a center, focus on verifying its official annual report for the relevant age group, rather than relying on online reputation.

Q. Frequently Asked Questions
"I am 40 years old with AMH 0.9. How many cycles should I prepare for IVF in Georgia?"
Based on empirical data, the 40–42 age group typically requires an average of 2–3 complete cycles (including stimulation and transfer) to achieve one live birth. It is advisable to allow 6–12 months.

⚠️ Risk Reminder
① Some reproductive centers in Georgia still use standard long protocols for older patients, leading to suboptimal egg quantity and quality. It is recommended to ask the doctor for their institution's age-stratified live birth rate data from the past year during the initial consultation.
② Embryo chromosomal abnormalities are a natural law. No medication or technology can reverse the age-related decline in egg quality. Patients over 40 should be mentally prepared for the possibility of needing multiple cycles or egg donation.
③ Luteal phase support protocols vary significantly. In Georgia, oral dydrogesterone plus vaginal progesterone gel is commonly used, but some patients absorb the gel poorly. If repeated transfers fail, consider monitoring serum progesterone levels (a peak of ≥10 ng/mL is needed to adequately support early pregnancy).